Home
Add Document
Sign In
Create An Account
Beta Hemolytic Streptococcus
GRANDE RONDE HOSPITAL ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016 Beta Hemolytic Streptococcus Inpatient and Outpatient Is...
Author:
Kristina Lynch
5 downloads
0 Views
81KB Size
Report
Download PDF
Recommend Documents
Streptococcus. Streptococcus-1
UniVerse. BASIC SQL Client Interface Guide. Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta
Hemolytic Uremic Syndrome
STREPTOCOCCUS PYOGENES:
Validity of Rapid Antigen Detection Testing in Group A Beta-Hemolytic Streptococcal Tonsillopharyngitis
Streptococcus faecalis
Bacteriocine in Streptococcus pneumoniae
MECHANIZMY WIRULENCJI STREPTOCOCCUS PYOGENES
Beta
Peritonitis primaria por Streptococcus pyogenes
Streptococcus: Eine szientometrische Analyse
Streptococcus uberis. Un nuevo reto
Review Article Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
Immune-mediated hemolytic anemia (IMHA) is
Meningoencefalitis bacteriana a Streptococcus pneumoniae
Backup Exec Panther Beta BETA Scripts. Contents
Wired Microphones BETA 98AMP BETA 98AMP
Beta- & Neutronenstrahlenexpositionen
Talasemia Beta
Plasmatherapy in Atypical Hemolytic Uremic Syndrome
Immune-mediated hemolytic anemia (IMHA) is
Interference between Streptococcus pneumoniae and Staphylococcus aureus: In Vitro Hydrogen Peroxide-Mediated Killing by Streptococcus pneumoniae
beta ratio
Los cuadros de bacteriemia por Streptococcus bovis
GRANDE RONDE HOSPITAL
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Beta Hemolytic Streptococcus Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefuroxime
2nd Generation Cephalosporin
2
100
Cefotaxime
3rd Generation Cephalosporin
18
100
Ceftriaxone
3rd Generation Cephalosporin
18
100
Cefepime
4th Generation Cephalosporin
18
100
Ertapenem
Beta Lactam
18
94
Meropenem
Beta Lactam
19
100
Levofloxacin
Fluoroquinolone
19
100
Azithromycin
Macrolide
15
67
Erythromycin
Macrolide
15
67
Clindamycin
Other
15
67
Daptomycin
Other
17
100
Vancomycin
Other
19
100
Amoxicillin/Clav
Penicillin/Beta Lactam
17
100
Penicillin
Penicillins
17
100
Tetracycline
Tetracyclines
19
42
Page 1 of 14
NOTES
All isolates have been tested for inducible Clindamycin resistance
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Citrobacter spp Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefazolin
1st Generation Cephalosporin
34
0
Ceftazidime
3rd Generation Cephalosporin
35
94
Ceftriaxone
3rd Generation Cephalosporin
35
91
Cefepime
4th Generation Cephalosporin
35
100
Amikacin
Aminoglycoside
35
100
Gentamicin
Aminoglycoside
35
97
Ertapenem
Beta Lactam
35
97
Meropenem
Beta Lactam
35
100
Ciprofloxacin
Fluoroquinolone
34
91
Levofloxacin
Fluoroquinolone
34
91
Aztreonam
Monobactam
35
91
Nitrofurantoin
Other
31
84
Ampicillin/Sulbactam
Penicillin/Beta Lactam
35
63
Piperacillin/Tazobactam
Penicillin/Beta Lactam
35
100
Ampicillin
Penicillins
35
0
Trimeth/Sulfa
Sulfonamides
35
80
Tetracycline
Tetracyclines
34
79
Page 2 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Coag Neg Staph Group Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Gentamicin
Aminoglycoside
78
95
Ciprofloxacin
Fluoroquinolone
78
56
Levofloxacin
Fluoroquinolone
78
58
Erythromycin
Macrolide
41
41
Clindamycin
Other
41
76
Daptomycin
Other
77
100
Linezolid
Other
78
100
Nitrofurantoin
Other
37
100
Rifampin
Other
78
100
Vancomycin
Other
78
100
Ampicillin
Penicillins
78
0
Oxacillin
Penicillins
78
54
Penicillin
Penicillins
78
0
Trimeth/Sulfa
Sulfonamides
78
64
Tetracycline
Tetracyclines
78
82
Page 3 of 14
NOTES
All isolates have been tested for inducible Clindamycin resistance
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Enterobacter spp Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefazolin
1st Generation Cephalosporin
50
0
Ceftazidime
3rd Generation Cephalosporin
50
96
Ceftriaxone
3rd Generation Cephalosporin
50
92
Cefepime
4th Generation Cephalosporin
50
100
Amikacin
Aminoglycoside
50
100
Gentamicin
Aminoglycoside
50
98
Ertapenem
Beta Lactam
50
100
Meropenem
Beta Lactam
50
100
Ciprofloxacin
Fluoroquinolone
50
94
Levofloxacin
Fluoroquinolone
50
96
Aztreonam
Monobactam
50
94
Nitrofurantoin
Other
35
83
Ampicillin/Sulbactam
Penicillin/Beta Lactam
50
0
Piperacillin/Tazobactam
Penicillin/Beta Lactam
50
98
Ampicillin
Penicillins
50
0
Trimeth/Sulfa
Sulfonamides
50
90
Tetracycline
Tetracyclines
50
88
Page 4 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Enterococcus spp Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
NOTES
Gentamicin 500ug/mL
Aminoglycoside
104
88
Synergy Testing
Streptomycin 1000ug/mL
Aminoglycoside
104
85
Synergy Testing
Ciprofloxacin
Fluoroquinolone
86
65
Levofloxacin
Fluoroquinolone
87
72
Erythromycin
Macrolide
18
39
Daptomycin
Other
103
100
Linezolid
Other
105
97
Nitrofurantoin
Other
86
93
Rifampin
Other
104
70
Vancomycin
Other
105
97
Ampicillin
Penicillins
104
94
Penicillin
Penicillins
105
92
Page 5 of 14
2 VRE
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Escherichia coli Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefazolin
1st Generation Cephalosporin
715
93
Ceftazidime
3rd Generation Cephalosporin
715
99
Ceftriaxone
3rd Generation Cephalosporin
715
95
Cefepime
4th Generation Cephalosporin
715
99
Amikacin
Aminoglycoside
715
100
Gentamicin
Aminoglycoside
715
95
Ertapenem
Beta Lactam
715
100
Meropenem
Beta Lactam
715
100
Ciprofloxacin
Fluoroquinolone
715
88
Levofloxacin
Fluoroquinolone
715
89
Aztreonam
Monobactam
715
97
Nitrofurantoin
Other
683
99
Ampicillin/Sulbactam
Penicillin/Beta Lactam
715
76
Piperacillin/Tazobactam
Penicillin/Beta Lactam
715
100
Ampicillin
Penicillins
715
66
Trimeth/Sulfa
Sulfonamides
715
83
Tetracycline
Tetracyclines
715
82
Page 6 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Haemophilus influenza Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefuroxime
2nd Generation Cephalosporin
23
100
Ceftriaxone
3rd Generation Cephalosporin
23
100
Cefepime
4th Generation Cephalosporin
23
100
Levofloxacin
Fluoroquinolone
18
100
Clarithromycin
Macrolide
23
70
Amoxicillin/Clav
Penicillin/Beta Lactam
23
96
Ampicillin/Sulbactam
Penicillin/Beta Lactam
23
96
Ampicillin
Penicillins
23
74
Trimeth/Sulfa
Sulfonamides
23
48
Tetracycline
Tetracyclines
23
100
Page 7 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Klebsiella spp Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefazolin
1st Generation Cephalosporin
149
84
Ceftazidime
3rd Generation Cephalosporin
149
98
Ceftriaxone
3rd Generation Cephalosporin
149
98
Cefepime
4th Generation Cephalosporin
149
99
Amikacin
Aminoglycoside
149
99
Gentamicin
Aminoglycoside
149
98
Ertapenem
Beta Lactam
149
99
Meropenem
Beta Lactam
149
99
Ciprofloxacin
Fluoroquinolone
149
97
Levofloxacin
Fluoroquinolone
149
97
Aztreonam
Monobactam
149
99
Nitrofurantoin
Other
120
93
Ampicillin/Sulbactam
Penicillin/Beta Lactam
149
91
Piperacillin/Tazobactam
Penicillin/Beta Lactam
149
100
Ampicillin
Penicillins
149
0
Trimeth/Sulfa
Sulfonamides
149
91
Tetracycline
Tetracyclines
149
94
Page 8 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Proteus/Morganella/Providencia spp Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefazolin
1st Generation Cephalosporin
58
40
Ceftazidime
3rd Generation Cephalosporin
58
100
Ceftriaxone
3rd Generation Cephalosporin
58
98
Cefepime
4th Generation Cephalosporin
58
100
Amikacin
Aminoglycoside
58
100
Gentamicin
Aminoglycoside
58
97
Meropenem
Beta Lactam
58
91
Ciprofloxacin
Fluoroquinolone
58
76
Levofloxacin
Fluoroquinolone
58
81
Aztreonam
Monobactam
58
100
Nitrofurantoin
Other
47
0
Ampicillin/Sulbactam
Penicillin/Beta Lactam
58
81
Piperacillin/Tazobactam
Penicillin/Beta Lactam
58
100
Ampicillin
Penicillins
58
45
Trimeth/Sulfa
Sulfonamides
58
84
Tetracycline
Tetracyclines
58
0
Page 9 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Pseudomonas aeruginosa Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Ceftazidime
3rd Generation Cephalosporin
47
96
Cefepime
4th Generation Cephalosporin
47
98
Gentamicin
Aminoglycoside
47
100
Meropenem
Beta Lactam
47
96
Ciprofloxacin
Fluoroquinolone
47
85
Levofloxacin
Fluoroquinolone
47
87
Aztreonam
Monobactam
47
89
Piperacillin/Tazobactam
Penicillin/Beta Lactam
47
98
Page 10 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Staph aureus (MRSA) Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Gentamicin
Aminoglycoside
148
98
Ciprofloxacin
Fluoroquinolone
148
11
Levofloxacin
Fluoroquinolone
148
14
Erythromycin
Macrolide
136
5
Clindamycin
Other
136
84
Daptomycin
Other
147
100
Linezolid
Other
148
100
Nitrofurantoin
Other
12
100
Rifampin
Other
148
100
Vancomycin
Other
148
100
Ampicillin
Penicillins
148
0
Oxacillin
Penicillins
148
0
Penicillin
Penicillins
148
0
Trimeth/Sulfa
Sulfonamides
148
99
Tetracycline
Tetracyclines
148
95
Page 11 of 14
NOTES
All isolates have been tested for inducible Clindamycin resistance
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Staph aureus (not MRSA) Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Gentamicin
Aminoglycoside
183
100
Ciprofloxacin
Fluoroquinolone
183
85
Levofloxacin
Fluoroquinolone
183
87
Erythromycin
Macrolide
161
73
Clindamycin
Other
161
90
Daptomycin
Other
183
100
Nitrofurantoin
Other
22
100
Rifampin
Other
183
99
Vancomycin
Other
183
100
Ampicillin
Penicillins
182
0
Oxacillin
Penicillins
183
100
Penicillin
Penicillins
183
0
Trimeth/Sulfa
Sulfonamides
183
99
Tetracycline
Tetracyclines
183
95
Page 12 of 14
NOTES
All isolates have been tested for inducible Clindamycin resistance
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
Streptococcus pneumoniae Inpatient and Outpatient Isolates have been combined
ANTIBIOTIC
CLASS
Number of Isolates
% SUSCEPTIBLE
Cefuroxime
2nd Generation Cephalosporin
21
86
Cefotaxime (meningitis)
3rd Generation Cephalosporin
3
67
Cefotaxime (non-meningitis)
3rd Generation Cephalosporin
3
100
Ceftriaxone (meningitis)
3rd Generation Cephalosporin
4
75
Ceftriaxone (non-meningitis)
3rd Generation Cephalosporin
4
100
Levofloxacin
Fluoroquinolone
21
100
Azithromycin
Macrolide
20
80
Erythromycin
Macrolide
20
80
Vancomycin
Other
21
100
Amoxicillin/Clav
Penicillin/Beta Lactam
21
100
Penicillin (meningitis)
Penicillins
4
0
Penicillin (non-meningitis)
Penicillins
4
100
Trimeth/Sulfa
Sulfonamides
21
90
Tetracycline
Tetracyclines
21
90
Page 13 of 14
NOTES
Printed: 01/18/2017
ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016
CLSI STAPH VS BETA LACTAM SUSCEPTIBILITY IF PCN AND OXACILLIN SUSCEPTIBLE
IF PCN RESISTANT AND OXACILLIN SUSCEPTIBLE
IF PCN AND OXACILLIN RESISTANT
1st - CEFAZOLIN
susceptible
susceptible
resistant
1st - CEPHALEXIN
susceptible
susceptible
resistant
2nd - CEFPROZIL
susceptible
susceptible
resistant
2nd - CEFUROXIME
susceptible
susceptible
resistant
3rd - CEFDINIR
susceptible
susceptible
resistant
3rd - CEFOTAXIME
susceptible
susceptible
resistant
3rd - CEFTAZIDIME
susceptible
susceptible
resistant
3rd - CEFTRIAXONE
susceptible
susceptible
resistant
4th - CEFEPIME
susceptible
susceptible
resistant
ERTAPENEM
susceptible
susceptible
resistant
MEROPENEM
susceptible
susceptible
resistant
CEFOTETAN
susceptible
susceptible
resistant
CEFOXITIN
susceptible
susceptible
resistant
AMPICILLIN/ SULBACTAM
susceptible
susceptible
resistant
PIPERACILLIN/ TAZOBACTAM
susceptible
susceptible
resistant
AMOXICILLIN
susceptible
resistant
resistant
AMPICILLIN
susceptible
resistant
resistant
PEN G
susceptible
resistant
resistant
DICLOXACILLIN
susceptible
susceptible
resistant
NAFCILLIN
susceptible
susceptible
resistant
OXACILLIN
susceptible
susceptible
resistant
ANTIBIOTIC CLASS BETA LACTAMS (cephalosporins)
CARBEPENEMS
CEPHEMS
PENICILLINS (beta lactamase inhibitor combo)
PENICILLINS (penicillinase labile)
PENICILLINS (penicillinase stable)
Page 14 of 14
ANTIBIOTIC
Printed: 01/18/2017
Suggest Documents
Streptococcus. Streptococcus-1
Read more
UniVerse. BASIC SQL Client Interface Guide. Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta Beta
Read more
Hemolytic Uremic Syndrome
Read more
STREPTOCOCCUS PYOGENES:
Read more
Validity of Rapid Antigen Detection Testing in Group A Beta-Hemolytic Streptococcal Tonsillopharyngitis
Read more
Streptococcus faecalis
Read more
Bacteriocine in Streptococcus pneumoniae
Read more
MECHANIZMY WIRULENCJI STREPTOCOCCUS PYOGENES
Read more
Beta
Read more
Peritonitis primaria por Streptococcus pyogenes
Read more
Streptococcus: Eine szientometrische Analyse
Read more
Streptococcus uberis. Un nuevo reto
Read more
Review Article Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
Read more
Immune-mediated hemolytic anemia (IMHA) is
Read more
Meningoencefalitis bacteriana a Streptococcus pneumoniae
Read more
Backup Exec Panther Beta BETA Scripts. Contents
Read more
Wired Microphones BETA 98AMP BETA 98AMP
Read more
Beta- & Neutronenstrahlenexpositionen
Read more
Talasemia Beta
Read more
Plasmatherapy in Atypical Hemolytic Uremic Syndrome
Read more
Immune-mediated hemolytic anemia (IMHA) is
Read more
Interference between Streptococcus pneumoniae and Staphylococcus aureus: In Vitro Hydrogen Peroxide-Mediated Killing by Streptococcus pneumoniae
Read more
beta ratio
Read more
Los cuadros de bacteriemia por Streptococcus bovis
Read more
×
Report "Beta Hemolytic Streptococcus"
Your name
Email
Reason
-Select Reason-
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Description
×
Sign In
Email
Password
Remember me
Forgot password?
Sign In
Login with Google
Login with Facebook